Failure of gamma-interferon to decrease mortality from group B streptococcal sepsis in neonatal rats

Biology of the Neonate

Volumn 76, Issue 2, 1999, Pages 125-128

  Wittler, Robert R ^a,b   Harris, Richard W ^a   Paine, Donald D ^a  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

Gamma interferon; Group B streptococcal sepsis; Neonate; Rat

Indexed keywords

GAMMA INTERFERON; PENICILLIN G; RECOMBINANT GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MORTALITY; NEUTROPHIL CHEMOTAXIS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SURVIVAL RATE;

ANIMALS; ANIMALS, NEWBORN; BACTEREMIA; INTERFERON-GAMMA, RECOMBINANT; PENICILLINS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SURVIVAL RATE;

EID: 0032810896     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014151     Document Type: Article

References (15)

1. Baker C, Edwards M: Group B streptococcal infections; in Remington J, Klein J (eds): Infectious Diseases of the Fetus and Newborn, ed 4. Philadelphia, Saunders, 1995, pp 980-1054.
2. Mease AD: Tissue neutropenia: The newborn neutrophil in perspective. J Perinatol 1990;10:55-59.
3. Quie PG: Antimicrobial defenses in the neonate. Semin Perinatol 1990; 14(suppl 1):2-9.
4. Hill H: Modulation of host defenses with interferon-y in pediatrics. J Infect Dis 1993;167:S23-S28.
5. Miller ME: Chemotactic function in the human neonate: Humoral and cellular aspects. Pediatr Res 1971;5: 487-492.
6. Klein RB, Fischer TJ, Gard SE, Biberstein M, Rich KC, Stiehm ER: Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics 1977;60:467-472.
7. Hill H, Augustine N, Jaffe H: Human recombinant interferon enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J Exp Med 1991;173:767-770.
8. Wilson CB, Lewis DB: Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 1990;12:S410-S420.
9. Buckle A, Hogg N: The effect of IFN-γ and colony stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol 1989;143:2295-2301.
10. Buckle AM, Hogg N: Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin-2 and interferon-gamma. Eur J Immunol 1990; 20:337-341.
11. Dijkmans R, Billiau A: Interferon γ: A master key in the immune system. Curr Opin Immunol 1988;1:269-274.
12. Bortolussi R, Issekutz T, Burbridge S, Schellekens H: Neonatal host defense mechanisms against Listeria monocytogenes infection: The role of lipopolysaccharides and interferons. Pediatr Res 1989;25:311-315.
13. Cairo MS, Mauss D, Kommareddy S, Norris K. Van de Yen C, Modanolou H: Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res 1990;27: 612-616.
14. Novales JS, Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Andresen J, Medlock ES: Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood 1993; 81:923-927.
15. Cusumano V, Mancuso G, Genovese F, Delfino D, Beninati C, Losi E, Teti G: Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect Immun 1996;64:2941-2944.